Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0000950142-14-000705
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-21 20:08:55
Reporting Period:
2014-03-20
Filing Date:
2014-03-21
Accepted Time:
2014-03-21 20:08:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1544116 Durata Therapeutics Inc. DRTX Pharmaceutical Preparations (2834) 871247903
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1172252 N Andrew Schiff 888 Seventh Avenue
30Th Fl
New York NY 10106
No No Yes No
1250195 Steve Elms 888 Seventh Avenue
30Th Fl
New York NY 10106
No No Yes No
1297291 J Dennis Purcell 888 Seventh Avenue
30Th Fl
New York NY 10106
No No Yes No
1444717 Aisling Capital Iii Lp 888 Seventh Avenue
30Th Fl
New York NY 10106
No No Yes No
1532634 Aisling Capital Partners Iii Lp 888 Seventh Avenue
30Th Fl
New York NY 10106
No No Yes No
1532635 Aisling Capital Partners Iii Llc 888 Seventh Avenue
30Th Fl
New York NY 10106
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-03-20 98,000 $15.74 3,032,824 No 4 S Indirect By Aisling Capital III, LP
Common Stock Disposition 2014-03-21 2,649 $15.57 3,030,175 No 4 S Indirect By Aisling Capital III, LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Aisling Capital III, LP
No 4 S Indirect By Aisling Capital III, LP
Footnotes
  1. These shares of common stock are owned directly by Aisling Capital III, LP ("Aisling"), and held indirectly by Aisling Capital Partners III, LP ("Aisling GP") , as general partner of Aisling, Aisling Capital Partners III LLC ("Aisling Partners"), as general partner of Aisling GP, and each of the individual managing members of Aisling Partners. The individual managing members (collectively, the "Managers") of Aisling Partners are Dennis Purcell, Dr. Andrew Schiff and Steve Elms. Aisling GP, Aisling Partners and the Managers share voting and dispositive power over the shares directly held by Aisling. (Continued in FN 2)
  2. (Continued from FN 1) Pursuant to Rule 16a-1(a)(2)(ii)(B) under the Securities Exchange Act of 1934, as amended (the "Act"), each of the Reporting Persons may be deemed to be the beneficial owner of the securities reported herein only to the extent of its pecuniary interest therein. Pursuant to Rule 16a-1(a)(4) under the Act, this filing shall not be deemed an admission that any of the Reporting Persons is, for purposes of Section 16 of the Act or otherwise, the beneficial owner of any securities reported herein in excess of such amount.